Company Quick10K Filing
Express Scripts
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 568 $53,843
10-Q 2018-10-31 Quarter: 2018-09-30
10-Q 2018-08-01 Quarter: 2018-06-30
10-Q 2018-05-02 Quarter: 2018-03-31
10-K 2018-02-27 Annual: 2017-12-31
10-Q 2017-10-24 Quarter: 2017-09-30
10-Q 2017-07-25 Quarter: 2017-06-30
10-Q 2017-04-24 Quarter: 2017-03-31
10-K 2017-02-14 Annual: 2016-12-31
10-Q 2016-10-25 Quarter: 2016-09-30
10-Q 2016-07-25 Quarter: 2016-06-30
10-Q 2016-04-25 Quarter: 2016-03-31
10-K 2016-02-16 Annual: 2015-12-31
10-Q 2015-10-27 Quarter: 2015-09-30
10-Q 2015-07-28 Quarter: 2015-06-30
10-Q 2015-04-28 Quarter: 2015-03-31
10-K 2015-02-23 Annual: 2014-12-31
10-Q 2014-10-28 Quarter: 2014-09-30
10-Q 2014-07-29 Quarter: 2014-06-30
10-Q 2014-04-29 Quarter: 2014-03-31
10-K 2014-02-20 Annual: 2013-12-31
10-Q 2013-10-24 Quarter: 2013-09-30
10-Q 2013-07-29 Quarter: 2013-06-30
10-Q 2013-04-29 Quarter: 2013-03-31
10-K 2013-02-19 Annual: 2012-12-31
10-Q 2012-11-06 Quarter: 2012-09-30
10-Q 2012-08-07 Quarter: 2012-06-30
10-Q 2012-05-10 Quarter: 2012-03-31
8-K 2018-12-20 M&A, Off-BS Arrangement, Shareholder Rights, Control, Officers, Amend Bylaw, Other Events, Exhibits
8-K 2018-12-18 Regulation FD
8-K 2018-12-13 Regulation FD
8-K 2018-11-21 Enter Agreement, Regulation FD, Exhibits
8-K 2018-10-31 Earnings, Regulation FD, Exhibits
8-K 2018-09-17 Other Events, Exhibits
8-K 2018-08-29 Regulation FD
8-K 2018-08-24 Shareholder Vote, Other Events, Exhibits
8-K 2018-08-13 Other Events, Exhibits
8-K 2018-08-10 Other Events, Exhibits
8-K 2018-08-08 Regulation FD, Exhibits
8-K 2018-08-01 Earnings, Regulation FD, Exhibits
8-K 2018-06-27 Enter Agreement, Exhibits
8-K 2018-05-10 Shareholder Vote
8-K 2018-05-02 Earnings, Regulation FD, Exhibits
8-K 2018-04-25 Regulation FD, Exhibits
8-K 2018-04-23 Other Events
8-K 2018-03-08 Enter Agreement, Amend Bylaw, Exhibits
8-K 2018-03-08 Other Events, Exhibits
8-K 2018-02-27 Earnings, Regulation FD, Exhibits
8-K 2018-01-24 Officers

Express Scripts Financials

ESRX Metrics, Comps, Filings

Annual | Quarterly

Business

Prescription drugs play a significant role in healthcare today and constitute the first line of treatment for many medical conditions. For many, prescription drugs provide the hope of improved health and quality of life.

Total medical costs for employers continue to outpace the rate of overall inflation, in particular, the increase in high cost drugs to treat complex conditions such as cancer, hepatitis and multiple sclerosis. National health expenditures as a percentage of gross domestic product are expected to increase to 20% in 2026 from 18% in 2017 according to the Centers for Medicare & Medicaid Services ("CMS"). With increasing cost pressures being exerted on health benefit providers such as managed care organizations, health insurers, employers and unions, there is an increasing role for pharmacy benefit management ("PBM") companies to develop innovative strategies to put medicine within reach of patients by making better health more affordable and accessible.

PBM companies typically combine retail pharmacy claims processing and network management, formulary management, utilization management and home delivery pharmacy services to develop an integrated product offering to manage the prescription drug benefit for payors. Some PBMs also offer specialty medication services that deliver a more effective solution than many retail pharmacies in providing treatments for diseases that rely upon high-cost injectable, infused, oral or inhaled drugs. Some PBMs have also broadened their service offerings to include medication adherence programs, outcomes research, drug therapy management programs, sophisticated data analysis and distribution services.


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Stockholders' Equity

Income Statement ($BB Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($BB Annual)

Operating, Investing, Financing

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Atreca (BCEL) 90,348 -5,033.4 -8% 227 8 0 0 -18 -18 90,193
Uber (UBER) 76,613 0% -12.1 -20% 30,980 15,072 6,265 0 -6,248 -5,579 67,526
Time Warner (TWX) 74,606 43% 9.5 8% 68,997 39,192 31,532 13,501 5,786 9,576 91,246
Aetna (AET) 66,578 49% 12.6 6% 57,103 38,540 61,233 30,264 3,690 5,387 67,966
Dell (DVMT) 60,080 30% 18.7 3% 115,520 111,401 91,601 27,175 3,386 5,498 102,737
Express Scripts (ESRX) 53,843 9% 9.4 9% 55,442 34,869 101,353 8,926 4,910 6,726 63,111
Praxair (PX) 47,321 0% 14.6 8% 19,979 13,229 12,037 0 1,508 3,763 54,918
SPDR Gold Trust (GLD) 35,933 9.6 10% 36,143 184 0 0 3,747 3,747 35,933
Brown Forman (BFB) 30,994 53% 27.8 15% 5,322 3,659 4,064 2,141 821 1,187 32,954
Woori Bank (WF) 29,676 0% 340,447,183 318,494,139 0 0 0 0 29,676
Hanwha Q Cells (HQCL) 29,263 0% 2,263 1,807 0 0 0 0 29,179
Rockwell Collins (COL) 23,197 75% 12.5 5% 19,026 11,919 8,665 6,467 1,032 1,803 22,459
Zoom Video (ZM) 23,039 81% 1,390.7 1% 1,070 326 268 216 8 16 22,823
Coca-Cola European Partners (CCE) 21,514 0% 18,216 11,652 0 0 0 0 21,235
Andeavor (ANDV) 19,940 11.4 8% 30,074 16,507 0 0 2,328 2,491 28,352
Lyft (LYFT) 18,822 33% -10.6 -31% 5,704 2,427 1,643 550 -1,783 -1,726 18,280
CA (CA) 18,329 0% 11.9 3% 13,103 5,201 4,009 0 409 1,507 17,903
Spectra Energy Partners (SEP) 17,408 0% 18.1 3% 22,411 10,409 2,104 0 697 1,402 25,407
Crypto (CRCW) 12,197 -77% -758.6 -5,751% 0 1 -1 1 -17 -16 12,198
Pinterest (PINS) 12,072 61% -8.9 -50% 2,387 314 463 284 -1,201 -1,189 10,637

Balance Sheet ($MM)2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-31
Cash04035840
Accounts Receivable4,102
Inventory1,6621,8712,1132,0231,9592,125
PP&E1,3092,7515403
Assets16,33346,70843,37042,42144,96341,041
Accounts Payable2,29563409503,756
Long-Term Debt14,43613,80013,46615,57515,56816,112
Liabilities34,71631,70333,73535,86335,50136,130
Stockholders' Equity23,38533,43432,79833,00516,23635,169
Income Statement ($MM)2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-31
Revenue9691,2311,5821,9951,6611,806
Cost of Revenue86,52895,96692,96293,35091,66791,302
Gross Profit7,3308,1327,9258,4028,6208,762
R&D
SG&A4,5464,5814,3234,0633,5333,268
Tax-20931,3111,8021,543-688
Net Income879395-636943,4041,335
Cash Flow ($MM)2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-31
Cash Operating4,7524,7694,5491,146-15509
Cash Investing-10,4290-4120287
Cash Financing2,850-762-4,290-1,144598-601